What is the address of MANUELE THERAPIE EN REVALIDATIE?

The registered office of MANUELE THERAPIE EN REVALIDATIE is located at Houterstraat 49 box 1, 3620 Lanaken.

Is MANUELE THERAPIE EN REVALIDATIE still active?

Yes. According to the CBE (30 September 2026) MANUELE THERAPIE EN REVALIDATIE is active, legal situation “Normale toestand”, started on 26 April 2011.

Is MANUELE THERAPIE EN REVALIDATIE registered on Peppol?

Yes, MANUELE THERAPIE EN REVALIDATIE is registered on the Peppol network with ID 0208:0835897005.

What is the enterprise number of MANUELE THERAPIE EN REVALIDATIE?

The enterprise number of MANUELE THERAPIE EN REVALIDATIE is BE0835897005.

When was MANUELE THERAPIE EN REVALIDATIE founded?

MANUELE THERAPIE EN REVALIDATIE was founded on 26 April 2011.

Who are the directors of MANUELE THERAPIE EN REVALIDATIE?

According to the 2025 annual accounts, the directors of MANUELE THERAPIE EN REVALIDATIE are: Koen Souverijns.

Is MANUELE THERAPIE EN REVALIDATIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 April 2011; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MANUELE THERAPIE EN REVALIDATIE make in 2025?

MANUELE THERAPIE EN REVALIDATIE posted a profit after taxes of € 4,758 in financial year 2025.

What is the revenue of MANUELE THERAPIE EN REVALIDATIE?

As a small company, MANUELE THERAPIE EN REVALIDATIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 67,075.

Does MANUELE THERAPIE EN REVALIDATIE have a website?

Yes, MANUELE THERAPIE EN REVALIDATIE has a website at 3bunders.be.

MANUELE THERAPIE EN REVALIDATIE (Private Limited)

Dossier MANUELE THERAPIE EN REVALIDATIE, printed on 30 September 2026 from databakkes.be/en/0835897005/manuele-therapie-en-revalidatie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 31 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

MANUELE THERAPIE EN REVALIDATIE from Lanaken, company number BE0835897005, closed financial year 2025 with a result of € 4,758 after tax. For that financial year MANUELE THERAPIE EN REVALIDATIE recorded a gross margin of € 67,075 and equity of € 44,994. Compared with financial year 2024, the result moved from € 3,513 to € 4,758. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.

What it is worth Growing

€ 44,994

▲ 12% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 4,758

▲ 35% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 34,112

▼ 59% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 26,394.

People and assets in 2025

Vehicles and equipment

€ 39,997

▼ 6% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 384,643

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 1,501

▼ 43% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 312

▲ 5% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 11,682 Gross margin 2022: € 11,682 First fiscal year in the series	€ 25,780 Gross margin 2023: € 25,780 ▲ 121% vs 2022 (€ 11,682) Favourable step	€ 23,478 Gross margin 2024: € 23,478 ▼ 9% vs 2023 (€ 25,780) Unfavourable step	€ 67,075 Gross margin 2025: € 67,075 ▲ 186% vs 2024 (€ 23,478) Favourable step	▲ 186%
Profit after taxes	€ -1,436 Profit after taxes 2022: € -1,436 First fiscal year in the series	€ 3,329 Profit after taxes 2023: € 3,329 ▲ € 4,766 vs 2022 (€ -1,436) Favourable step	€ 3,513 Profit after taxes 2024: € 3,513 ▲ 6% vs 2023 (€ 3,329) Favourable step	€ 4,758 Profit after taxes 2025: € 4,758 ▲ 35% vs 2024 (€ 3,513) Favourable step	▲ 35%
Equity	€ 33,394 Equity 2022: € 33,394 First fiscal year in the series	€ 36,723 Equity 2023: € 36,723 ▲ 10% vs 2022 (€ 33,394) Favourable step	€ 40,236 Equity 2024: € 40,236 ▲ 10% vs 2023 (€ 36,723) Favourable step	€ 44,994 Equity 2025: € 44,994 ▲ 12% vs 2024 (€ 40,236) Favourable step	▲ 12%
Total debts	€ 134,073 Total debts 2022: € 134,073 First fiscal year in the series	€ 147,307 Total debts 2023: € 147,307 ▲ 10% vs 2022 (€ 134,073) Unfavourable step	€ 141,337 Total debts 2024: € 141,337 ▼ 4% vs 2023 (€ 147,307) Favourable step	€ 537,925 Total debts 2025: € 537,925 ▲ 281% vs 2024 (€ 141,337) Unfavourable step	▲ 281%
Cash	€ 60,764 Cash 2022: € 60,764 First fiscal year in the series	€ 95,635 Cash 2023: € 95,635 ▲ 57% vs 2022 (€ 60,764) Favourable step	€ 84,215 Cash 2024: € 84,215 ▼ 12% vs 2023 (€ 95,635) Unfavourable step	€ 34,112 Cash 2025: € 34,112 ▼ 59% vs 2024 (€ 84,215) Unfavourable step	▼ 59%
Land & buildings	€ 46,218 Land & buildings 2022: € 46,218 First fiscal year in the series	€ 40,630 Land & buildings 2023: € 40,630 ▼ 12% vs 2022 (€ 46,218) Unchanged	€ 40,269 Land & buildings 2024: € 40,269 ▼ 1% vs 2023 (€ 40,630) Unchanged	€ 502,589 Land & buildings 2025: € 502,589 ▲ € 462,321 vs 2024 (€ 40,269) Unchanged	▲ € 462,321
Retained profit	€ 14,794 Retained profit 2022: € 14,794 First fiscal year in the series	€ 18,123 Retained profit 2023: € 18,123 ▲ 23% vs 2022 (€ 14,794) Favourable step	€ 21,636 Retained profit 2024: € 21,636 ▲ 19% vs 2023 (€ 18,123) Favourable step	€ 26,394 Retained profit 2025: € 26,394 ▲ 22% vs 2024 (€ 21,636) Favourable step	▲ 22%
Bank debt	€ 54,338 Bank debt 2022: € 54,338 First fiscal year in the series	€ 54,338 Bank debt 2023: € 54,338 Unchanged (€ 54,338) Unchanged	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 54,338) Favourable step	€ 384,643 Bank debt 2025: € 384,643 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 167,466 Balance sheet total 2022: € 167,466 First fiscal year in the series	€ 184,030 Balance sheet total 2023: € 184,030 ▲ 10% vs 2022 (€ 167,466) Unchanged	€ 181,573 Balance sheet total 2024: € 181,573 ▼ 1% vs 2023 (€ 184,030) Unchanged	€ 582,919 Balance sheet total 2025: € 582,919 ▲ 221% vs 2024 (€ 181,573) Unchanged	▲ 221%

Key figures of MANUELE THERAPIE EN REVALIDATIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MANUELE THERAPIE EN REVALIDATIE?

What happened at MANUELE THERAPIE EN REVALIDATIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 29, 2026 New annual accounts for financial year 2025: profit of € 4,758 (▲ 35% vs 2024). Source: NBB ↗
Apr 29, 2011 New establishment in Lanaken. KBO
Apr 26, 2011 Start of the company according to the CBE. KBO

In short

From € 1,436 loss in 2022 to € 4,758 profit in 2025.

Paid € 1,154 in corporate taxes since 2022.

Best year ever: 2025, with € 4,758 profit.

Original PDFs at the National Bank ↗

A new publication or filing at MANUELE THERAPIE EN REVALIDATIE? We notify you, reason included.

Follow MANUELE THERAPIE EN REVALIDATIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Koen Souverijns

MANUELE THERAPIE EN REVALIDATIE

Behind MANUELE THERAPIE EN REVALIDATIE is Koen Souverijns.

See the full network in the app

Directors

According to the 2025 annual accounts

Koen Souverijns

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Houterstraat 49 box 1

3620 Lanaken

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS 3bunders.be

Canonical: https://www.3bunders.be/

Technologies

ApacheBootstrapElementorFont AwesomeGoogle FontsPHPSwiperVarnishWordPressYoast SEOjQueryjQuery UI

Hosting & Email

Email provider

one.com Mail

Hosting

ONECOM, DK

Website info

HTTPS Ja

Languages NL

Features

Security

✓ HTTPS

✗ SPF

✗ DMARC

Network

✓ IPv6

Details

Company number: 0835.897.005
VAT number: BE 0835.897.005
Registered office: Houterstraat 49 bus 1, 3620 Lanaken
Names & denominations: MANUELE THERAPIE EN REVALIDATIE · MTR
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 26 April 2011
Peppol: Active · Active since 22 Dec 2025
Contact: 3bunders.be

View on CBE Public ↗ Annual accounts (NBB) ↗